French drug major Sanofi (SNYNF,SNY) reported third quarter net income attributable to equity holders of the company of 2.82 billion euros up from 2.53 billion euros in the prior year. IFRS earnings per share rose to 2.25 euros from 2.01 euros in the previous year.
Quarterly business net income increased to 3.59 billion euros from 3.20 billion euros in the prior year.
Business earnings per share was 2.86 euros, an increase of 12.2% on a reported basis or increase 17.6% at constant exchange rates or CER.
Net sales for the third quarter rose to 13.44 billion euros from 11.96 billion euros in the prior year.
On October 21, 2024, the 2024 business earnings per share guidance was upgraded to growth of at least a low single-digit percentage at CER supported by the underlying strong business performance. This reflects the new scope of guidance excluding Opella.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.